Neuroendocrine cell hyperplasia of infancy

MONDO:0016322

Neuroendocrine cell hyperplasia of infancy (NCHI) is a non-lethal pediatric form of interstitial lung disease (ILD) characterized by tachypnea without respiratory failure.

Also known as: CTI, NCHI, NEHI, chronic tachypnoe of infancy

62 clinical trials for this condition and its sub-types, 1 tagged with Neuroendocrine cell hyperplasia of infancy itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hyperplasia (273) ↑ Interstitial lung disease specific to infancy (2)

Including sub-types (62) Tagged with Neuroendocrine cell hyperplasia of infancy (1)

Trials to join now! 30 Not yet recruiting 10 Not yet finished but already full! 6 Completed 15 Terminated 1

Lung disease drug trial in kids halted early

Disease control Stopped early

This study tested whether hydroxychloroquine could help children with a rare lung condition called interstitial lung disease. About 35 children were planned to take either the drug or a placebo to see if their oxygen levels or breathing improved. The trial was stopped early, so r…

Phase 2 • Sponsor: Matthias Griese • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

Neuroendocrine cell hyperplasia of infancy

Where it sits in the disease tree

Lung disease drug trial in kids halted early